In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. (2020)

First Author: Rushworth LK
Attributed to:  Mechanistic determination of how microRNAs control gene-expression funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202000770

PubMed Identifier: 33033111

Publication URI: http://europepmc.org/abstract/MED/33033111

Type: Journal Article/Review

Volume: 3

Parent Publication: Life science alliance

Issue: 12

ISSN: 2575-1077